Rate of vertigo control higher after cochlear implantation alone versus endolymphatic sac surgery alone or with cochlear implant<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, Aug. 7, 2023 (HealthDay News) — For patients with Meniere disease (MD), vertigo control is improved with endolymphatic sac surgery alone (ESSalone<\/sup>), cochlear implantation alone (CIalone<\/sup>), and ESS with CI (ESS+CI), with the highest rate for CIalone<\/sup>, according to a study published online July 20 in the European Archives of Oto-Rhino-Laryngology<\/em>.<\/p>\n Jennifer L. Spiegel, M.D., from University Hospital in Munich, Germany, and colleagues conducted a retrospective data analysis of 86 consecutive patients with MD according to current diagnostic criteria after ESSalone<\/sup>, CIalone<\/sup>, and ESS+CI (45, 12, and 29 patients, respectively) treated at a tertiary referral center.<\/p>\n The researchers found that patients in the ESSalone<\/sup> group had younger age compared with CIalone<\/sup> or ESS+CI (56.2 \u00c2\u00b1 13.0 years versus 64.2 \u00c2\u00b1 11.4 and 63.1 \u00c2\u00b1 9.7 years, respectively). Definitive MD was seen in 100, 79.3, and 59.6 percent of the CIalone<\/sup>, ESS+CI, and ESSalone<\/sup> patients, respectively. The rate of vertigo control was 100, 89.7, and 66.0 percent in the CIalone<\/sup>, ESS+CI, and ESSalone<\/sup> groups, respectively.<\/p>\n “Data from the current study showed vertigo improvement after both ESS and CI,” the authors write. “However, it suggests a beneficial effect of CI surgery in comparison with ESS regarding vertigo control, potentially contributed by the manipulation of both the endo- and perilymphatic system.”<\/p>\n One author received travel expenses from pharmaceutical companies.<\/p>\n